Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts
Cheng Huang, Yi Jing Chen, Wei Jen Chen, Chih Li Lin, Yu Xuan Wei, Hsiu Chen Huang*
Research output: Contribution to journal › Article › peer-review
14Scopus
citations
Fingerprint
Dive into the research topics of 'Combined treatment with chrysin and 1,2,3,4,6-penta-O-galloyl-β-D-glucose synergistically inhibits LRP6 and Skp2 activation in triple-negative breast cancer and xenografts'. Together they form a unique fingerprint.